Indolent/Low Grade Non-Hodgkin’s Lymphoma

Lymphoma During Pregnancy Can Have Good Outcomes (03-14-2012)

Among women who are diagnosed with lymphoma during pregnancy, the outcomes for both mother and baby are often good. This was true for women who began lymphoma treatment during the second or third trimester of pregnancy, as well as women who deferred treatment... Continue Reading

Two Different Approaches to Rituxan Both Effective For Follicular Lymphoma (02-10-2012)

Among patients with low-tumor-burden follicular lymphoma who have received initial treatment with Rituxan® (rituximab), waiting until disease progression to take additional Rituxan is as effective as ongoing, maintenance Rituxan. These results were presented... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (05-23-2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients. For some patients, however, symptoms may persist... Continue Reading

Rituxan Approved as Maintenance Therapy for Follicular Lymphoma (02-10-2011)

The U.S. Food and Drug Administration (FDA) has expanded the approval of Rituxan® (rituximab) to include maintenance therapy for patients with advanced follicular lymphoma that has responded to initial treatment with Rituxan and chemotherapy. Follicular... Continue Reading

Rituxan Maintenance Shows Benefit in Follicular Lymphoma (12-22-2010)

Among patients with follicular lymphoma who responded to initial treatment with chemotherapy and Rituxan® (rituximab), those who received an additional two years of Rituxan as maintenance therapy remained free of lymphoma progression for longer than... Continue Reading

Rituxan Delays Need for Chemotherapy in Follicular Lymphoma (12-8-2010)

Compared with a watchful-waiting strategy, treatment with Rituxan® (rituximab) appears to delay the need for chemotherapy among patients with Stage II-IV, asymptomatic, non-bulky follicular lymphoma. These preliminary results were presented at the 52nd... Continue Reading

Maintenance Therapy with Rituxan Prolongs Lymphoma Remission (05-26-2010)

Among patients with follicular lymphoma who responded to initial treatment with chemotherapy and Rituxan® (rituximab), those who received an additional two years of Rituxan as maintenance therapy remained free of lymphoma progression for longer than... Continue Reading

Survivors of Some Childhood Cancers May Face Cognitive Impairment (05-18-2010)

Survivors of non-central nervous system (CNS) childhood cancers reported a statistically and clinically significantly higher rate of neurocognitive impairment than their cancer-free siblings, according to the results of a study published in the Journal... Continue Reading

Children and Teens Have Better NHL Survival than Young Adults (03-15-2010)

Even after accounting for stage at diagnosis and subtype of non-Hodgkin’s lymphoma (NHL), children and teens with NHL have better survival than young adults with NHL. These results were published in the Archives of Pediatrics and Adolescent Medicine. Non-Hodgkin’s... Continue Reading

Idiotype Vaccine Improves Disease-free Survival in Patients with Follicular Lymphoma (06-8-2009)

Idiotype Vaccine Improves Disease-free Survival in Patients with Follicular Lymphoma BiovaxID, an individualized tumor-specific protein vaccine, prolongs disease-free survival in patients with advanced follicular lymphoma who experience complete remission... Continue Reading

« Previous PageNext Page »